DiaMedica Therapeutics to be included in the Russell 2000 and 3000 indexes

* DiaMedica Therapeutics (NASDAQ:DMAC [https://seekingalpha.com/symbol/DMAC]) announced [https://seekingalpha.com/pr/20145627-diamedica-therapeutics-announces-inclusion-in-the-russell-2000-and-russell-3000-indexes] on Tuesday its upcoming addition as a member of the US small-cap Russell 2000 and Russell 3000 Indexes, effective after the U.S. market closes on June 27.
* The Russell 3000 Index encompasses the 3,000 largest U.S. companies by market capitalization. The Russell 2000 Index is a subset of the Russell 3000, measuring the performance of the small-cap segment.
* Shares of DiaMedica Therapeutics (NASDAQ:DMAC [https://seekingalpha.com/symbol/DMAC]) were up more than 2% in premarket trading.

MORE ON DIAMEDICA THERAPEUTICS

* DiaMedica Therapeutics Inc. (DMAC) Q1 2025 Earnings Call Transcript [https://seekingalpha.com/article/4786617-diamedica-therapeutics-inc-dmac-q1-2025-earnings-call-transcript]
* DiaMedica Therapeutics: Stroke Developer With Low Cash Reserve [https://seekingalpha.com/article/4775391-diamedica-therapeutics-stock-stroke-developer-low-cash-reserve]
* DiaMedica targets preeclampsia Phase 2 dose selection and ReMEDy2 interim analysis in H1 2026 as enrollment momentum builds [https://seekingalpha.com/news/4448064-diamedica-targets-preeclampsia-phase-2-dose-selection-and-remedy2-interim-analysis-in-h1-2026]
* DiaMedica Therapeutics GAAP EPS of -$0.18 in-line [https://seekingalpha.com/news/4447733-diamedica-therapeutics-gaap-eps-of--018-in-line]
* Seeking Alpha’s Quant Rating on DiaMedica Therapeutics [https://seekingalpha.com/symbol/DMAC/ratings/quant-ratings]